Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related Articles
Retina foundation showcases breakthroughs for treatment of age-related macular degeneration during eye on innovation conversation series Discovering New Therapies for AMD The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease Choroideremia Research Is Necessary to Help Prevent Blindness at an Early Age Retina Foundation Presents New Data & Conclusions at ARVO 2018